Why IGM Biosciences (IGMS) Stock Is Trading Higher

IGM Biosciences Inc IGMS shares are trading higher by 11.69% to $9.89 Thursday morning after the company priced upsized public offering and concurrent private placement at $8.00 per share.

The company's upsized underwritten public offering of 3,285,327 shares of voting common stock and 7,312,500 shares of non-voting common stock at $8.00 per share. Also, the underwriters have a 30-day option to purchase up to an additional 1,589,673 shares of voting common stock.

See Also: What's Going On With AMD Stock?

The public offering is expected to close around June 26. Additionally, IGM plans to sell 2,812,500 shares of non-voting common stock in a private placement to certain investors affiliated with Redmile Group, LLC, at $8.00 per share.

The total gross proceeds from the public offering and private placement are estimated to be approximately $107.3 million.

According to data from Benzinga Pro, IGMS has a 52-week high of $28.20 and a 52-week low of $8.50.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsSmall Capwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!